Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report
Sign Up to like & getrecommendations! Published in 2018 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-018-0231-9
Abstract: BackgroundThe approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored. Current options include new pituitary surgery and/or radiosurgery, or alternative medical treatment… read more here.
Keywords: treatment; case; cabergoline; pasireotide pegvisomant ... See more keywords